- Home
- PRLD vs AUID Comparison
PRLD vs AUID Comparison
Compare PRLD & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- AUID
- Stock Information
- Founded
- PRLD 2016
- AUID 2009
- Country
- PRLD United States
- AUID United States
- Employees
- PRLD N/A
- AUID 46
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- AUID Computer Software: Prepackaged Software
- Sector
- PRLD Health Care
- AUID Technology
- Exchange
- PRLD Nasdaq
- AUID Nasdaq
- Market Cap
- PRLD 50.1M
- AUID 72.6M
- IPO Year
- PRLD 2020
- AUID N/A
- Fundamental
- Price
- PRLD $0.89
- AUID $5.48
- Analyst Decision
- PRLD Strong Buy
- AUID
- Analyst Count
- PRLD 2
- AUID 0
- Target Price
- PRLD $4.50
- AUID N/A
- AVG Volume (30 Days)
- PRLD 137.5K
- AUID 212.9K
- Earning Date
- PRLD 05-06-2025
- AUID 05-13-2025
- Dividend Yield
- PRLD N/A
- AUID N/A
- EPS Growth
- PRLD N/A
- AUID N/A
- EPS
- PRLD N/A
- AUID N/A
- Revenue
- PRLD $7,000,000.00
- AUID $1,025,363.00
- Revenue This Year
- PRLD N/A
- AUID N/A
- Revenue Next Year
- PRLD N/A
- AUID N/A
- P/E Ratio
- PRLD N/A
- AUID N/A
- Revenue Growth
- PRLD N/A
- AUID 230.96
- 52 Week Low
- PRLD $0.61
- AUID $4.01
- 52 Week High
- PRLD $6.80
- AUID $12.31
- Technical
- Relative Strength Index (RSI)
- PRLD 51.42
- AUID 46.08
- Support Level
- PRLD $0.77
- AUID $4.90
- Resistance Level
- PRLD $1.00
- AUID $5.80
- Average True Range (ATR)
- PRLD 0.11
- AUID 0.55
- MACD
- PRLD -0.01
- AUID -0.00
- Stochastic Oscillator
- PRLD 37.18
- AUID 60.16
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.